Skip to main content
ConductScienceScienceDex

Beth Diane Kirkpatrick

NIH Rank #2653
Unclaimed recordClaim profile
  • Program Leader
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 2544457Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Microbiology & Immunology
  • Internal Medicine

NIH Funding · FY2024

Linked Award Amount
$3M
Full award amounts, FY2024
Award Records
4
Records listing this PI
Award-Linked Rank
#2,653
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Beth Diane Kirkpatrick. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Beth Diane Kirkpatrick as a PI. Multi-PI records show the full award amount for context.

  • 5U01AI134582-05U01
    A Phase II Evaluation of the Safety and Protective Efficacy of the Live Attenuated Tetravalent Dengue Vaccine TetraVax-DV with Challenge by the Recombinant DENV-2 Virus in a Dengue Endemic Population
    University of Vermont
    $1.2M
    award amount
  • 3P20GM125498-07S1P20
    Translational Research to Prevent and Control Global Infectious Diseases(Translational Global Infectious Diseases Research Center, TGIR)
    University of Vermont
    $956.4K
    award amount
  • 2U01AI141997-06U01
    Mechanisms of Protection and Durability for a Live Attenuated Tetravalent Dengue Vaccine
    University of Vermont
    $635.9K
    award amount
  • 5P20GM125498-07P20
    Translational Global Infectious Diseases Research Center
    University of Vermont
    $160.1K
    award amount

Award organization

Organizations that administered FY2024 awards listing Beth Diane Kirkpatrick as a PI.

FY2024 award administered by University of Vermont (VT).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Vermont
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2653
  6. 2024
    Entered Top 25% Nationally
    Ranked #2653
  7. 2025
    Program/Center Grant Leader

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Beth Diane Kirkpatrick.

Anna Palmer Durbin
University of Vermont
3
shared awards
Sean A. Diehl
University of Vermont
3
shared awards
Ashley Keller Volaric
University of Vermont
2
shared awards
Devdoot Majumdar
University of Vermont
2
shared awards
Emily A. Bruce
University of Vermont
2
shared awards
Kristen Pierce
University of Vermont
2
shared awards
Laurent Hébert-dufresne
University of Vermont
2
shared awards
Peter Hyson
University of Vermont
1
shared award
Sarah A Nowak
University of Vermont
1
shared award

Explore further

Find collaborators for Beth Diane Kirkpatrick

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →